Enterprise AI & Digital Platforms
I build the AI systems that make biopharma faster, smarter, and more competitive — from wiring 250+ enterprise systems into a single digital backbone to deploying agentic AI at scale.
"Most enterprises treat their SaaS stack as a cost center. I treat it as the foundation of an AI-native organization. The winners in biopharma won't be the ones who deployed the most models — they'll be the ones who had the courage to rewire how the whole operation works."
At Genmab, I lead enterprise-wide SaaS and digital platforms across the full biotech value chain — from research and clinical to regulatory and commercial. I'm a builder first: I get into the systems, make the hard architectural calls, and drive change that sticks in a regulated environment.
I connected 250+ disparate enterprise systems into a unified digital backbone — not a data lake, but a living, AI-native operating layer that enabled ML and NLP across regulatory and clinical workflows, driving 35–55% efficiency gains. That foundation now powers the next phase: agentic AI that acts, not just assists.
My team co-authored a peer-reviewed study published in Cancer Research (AACR 2025) on a mechanistically explainable AI model for predicting synergistic cancer therapy combinations — proof that digital infrastructure investments compound into scientific breakthroughs.
View full profile on LinkedIn →
Claude API · MCP · Enterprise AI Agents
Clinical · Regulatory · Commercial tech
Governed data lakes · GxP compliance · 250+ integrations
5K+ LinkedIn followers · Published essays on AI adoption
Enterprise-scale results in regulated environments.
Designed and deployed AI agent systems across enterprise operations — solving the adoption paradox by building AI proficiency at the ground level, not just the leadership layer.
Connected 250+ fragmented enterprise systems into a unified, AI-native operating layer — enabling ML and NLP deployment across regulatory and clinical workflows, delivering 35–55% efficiency gains across the org.
Transforming enterprise SaaS from cost center to competitive advantage — leading platform consolidation, vendor strategy, and digital capability building across the full biopharma value chain.
Built IT quality and validation frameworks for regulated biotech environments — enabling digital transformation while maintaining compliance with FDA, EMA, and ICH guidelines.
Essays on AI, biopharma, and what comes next. Read by 5,000+ leaders.
Co-authored with the Genmab data sciences team. An LLM + knowledge graph framework trained on 50,000+ in vitro drug pair assays — achieving an F1 score of 0.80 in predicting synergistic oncology combinations with full mechanistic explainability. Published in Cancer Research.
Read in Cancer Research →Organizations race to scale AI but the real bottleneck isn't technology — it's ground-level proficiency. Here's the framework to close the gap before deployments stall.
Read on LinkedIn →Why Model Context Protocol standardization is the hidden infrastructure decision that will define enterprise AI competitiveness in regulated biopharma environments.
Read on LinkedIn →New insights published weekly.
Follow on LinkedIn →Saurav Ghosh specializes in enterprise AI adoption, agentic AI systems, and digital platform strategy in the biopharma industry. He leads enterprise-wide SaaS and digital platforms at Genmab, with deep expertise in governed data infrastructure, Model Context Protocol (MCP), and building AI systems that operate in regulated GxP environments.
Saurav Ghosh is a senior leader at Genmab based in Princeton, NJ, educated at Stanford University. He is a hands-on builder known for wiring 250+ enterprise systems into a unified digital operating layer and co-authoring peer-reviewed AI research published in Cancer Research (AACR 2025). His work spans digital transformation, enterprise AI deployment, and building AI-native organizations in regulated biopharma environments.
The enterprise agentic adoption paradox refers to the gap between organizational ambition to deploy AI agents and the reality that ground-level teams lack the AI proficiency to use them effectively. Saurav Ghosh coined this framing to describe why many enterprise AI deployments fail: the bottleneck is human readiness, not technology capability.
Saurav Ghosh publishes thought leadership on LinkedIn at linkedin.com/in/ghoshsaurav, where he has built a following of 5,000+ professionals in biopharma, digital health, and enterprise AI. His topics include agentic AI adoption, Model Context Protocol, and digital transformation strategy in life sciences.
Yes. Saurav Ghosh is available for advisory conversations on enterprise AI strategy, biopharma digital transformation, and AI governance in regulated environments. For speaking engagements, advisory inquiries, or media requests, use the contact form below or connect via LinkedIn.
Saurav Ghosh works extensively with Claude API (Anthropic), Model Context Protocol (MCP), and enterprise agentic frameworks. His applied experience covers deploying AI agents across procurement, clinical operations, regulatory affairs, and commercial analytics in a large-cap biotech environment.
Whether you're exploring enterprise AI strategy, navigating digital transformation in a regulated environment, or want to talk through the adoption paradox — I'm always up for a sharp conversation.
Connect on LinkedIn